GW501516 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516, GW-501516, GW 501516, endurobol | Names vary in research and anti-doping documents. |
| Chemical class | Synthetic PPARδ agonist | Small-molecule nuclear receptor ligand. |
| CAS Registry Number | 317318-70-0 | Identifier commonly associated with GW501516. |
| Appearance | White to off-white powder | Typical for purified research material. |
| Solubility | Low in water; soluble in DMSO and ethanol | Organic solvents are common for laboratory stock solutions. |
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
==== Common causes ==== Bacterial infection from caries Thermal shock Trauma Excessive dehydration of a cavity during restoration Irritation of exposed dentine Repetitive trauma caused by bruxism or jaw misalignment Fractured tooth exposing pulp
23 May – Sunak confirms that no asylum seekers will be sent to Rwanda before the general election under UK government deportation plans. Nigel Farage, founder of Reform UK, confirms he will not stand as a candidate in the upcoming general election. Police Scotland announces that it has submitted a "standard prosecution report" concerning its investigation into SNP finances to the Crown Office and Procurator Fiscal Service. First Minister of Scotland John Swinney announces he will not accept a parliamentary committee ruling to exclude Michael Matheson from Holyrood for 27 days over his £11,000 iPad charges bill, saying the decision is "prejudiced" due to the involvement of a Conservative MSP who previously made comments about Matheson. 24 May – Sir John Redwood, MP for Wokingham, announces he will not contest the next election. Former Education Secretary Michael Gove announces he will not stand for parliament again at the next election. Junior health minister Andrea Leadsom announces she will not contest the next election. Craig Mackinlay decides he will not contest the new parliamentary seat of Thanet East after what he describes as "36 hours of intense soul searching" following the announcement of the election and his feeling that the work schedule would be too much to deal with while he continues to recover from sepsis. Greg Clark, MP for Tunbridge Wells, announces he will not contest the next general election.
α-Methylthiofentanyl is an opioid analgesic that is an analogue of fentanyl. α-Methylthiofentanyl was sold briefly on the black market in the early 1980s, before the introduction of the Federal Analog Act which for the first time attempted to control entire families of drugs based on their structural similarity rather than scheduling each drug individually as they appeared. α-Methylthiofentanyl has similar effects to fentanyl. Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear.
Sources: en.wikipedia.org
Silent mutations, also called synonymous or samesense mutations, are mutations in DNA that do not have an observable effect on the organism's phenotype, as they produce the same amino acid though a single base pairing has been altered. The phrase silent mutation is often used interchangeably with the phrase synonymous mutation; however, synonymous mutations are not always silent, nor vice versa. Synonymous mutations can affect transcription, splicing, mRNA transport, and translation, any of which could alter phenotype, rendering the synonymous mutation non-silent. The substrate specificity of the tRNA to the rare codon can affect the timing of translation, and in turn the co-translational folding of the protein. This is reflected in the codon usage bias that is observed in many species. Mutations that cause the altered codon to produce an amino acid with similar functionality (e.g. a mutation producing leucine instead of isoleucine) are often classified as silent; if the properties of the amino acid are conserved, this mutation does not usually significantly affect protein function.
=== Film and television === The 1925 film Little Annie Rooney takes place in the Bowery. The Bowery, a 1933 film about Brodie starring George Raft. The Bowery is portrayed in the 1934 Krazy Kat cartoon Bowery Daze. Bowery at Midnight, a 1942 Monogram Pictures horror film directed by Wallace Fox and starring Bela Lugosi and John Archer. The film was re-released by Astor Pictures in 1949. A popular B-movie series made between 1946 and 1958 featured "The Bowery Boys", led by Slip (Leo Gorcey) and Satch (Huntz Hall). The 1949 cartoon "Bowery Bugs" tells a fictionalized version of the Steve Brodie story, with Bugs Bunny as Brody's tormenter. On the Bowery, Lionel Rogosin's 1956 film, was nominated for the Academy Award for Best Documentary. In the 2002 film Gangs of New York, the Bowery is a mentioned territory of the Bowery Boys, a street gang of the late 19th century during the New York Draft Riots. A crime lord known as the Bowery King, portrayed by Laurence Fishburne, is a major character in the John Wick franchise. The Bowery Boys were a group of characters featured in a long-running series of 48 low-budget, comedic films, primarily produced by Monogram Pictures. While the films themselves weren't always set in the Bowery neighborhood of New York City, the name "Bowery Boys" was a nod to the characters' origins as Bowery B'hoys, a type of street gang from that area in the mid-19th century.
The enzyme responsible for the elicitation of the respiratory burst is known as nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which is composed of five subunits. One component is a membrane cytochrome made up of two protein subunits, gp91phox and p22phox; the remaining three components are cytosolic-derived proteins: p40phox, p47phox, and p67phox. NADPH oxidase exists in the cytosol of the AM when in a quiescent state; but upon activation, two of its cytosolic components, p47phox and p67phox, have their tyrosine and serine residues phosphorylated, which are then able to mediate translocation of NADPHox to the cytochrome component, gp91phox/p22phox, on the plasma membrane via cytoskeletal elements. Compared to other phagocytes, the respiratory burst in AM is of a greater magnitude. Oxygen-independent microbicidal mechanisms are based on the production of acid, on the secretion of lysozymes, on iron-binding proteins, and on the synthesis of toxic cationic polypeptides. Macrophages possess a repertoire of antimicrobial molecules packaged within their granules and lysosomes. These organelles contain a myriad of degradative enzymes and antimicrobial peptides that are released into the phagolysosome, such as proteases, nucleases, phosphatases, esterases, lipases, and highly basic peptides. Moreover, macrophages possess a number of nutrient deprivation mechanisms that are used to starve phagocytosed pathogens of essential micronutrients. Certain microorganisms have evolved countermeasures which enable them to evade being destroyed by phagocytes.
Sources: en.wikipedia.org
Antibody–drug conjugates or ADCs are a class of bioconjugates and immunoconjugates. ADCs are composed of an antibody linked to a cytotoxic (anticancer) "payload" or drug. Among treatment options for cancer, chemotherapy is most widely used. Its main limitation is low target specificity. Unlike chemotherapy, ADCs target tumor cells while sparing healthy cells. As of 2019, some 56 pharmaceutical companies were developing ADCs. ADCs combine the targeting properties of monoclonal antibodies with the cancer-killing capabilities of cytotoxic drugs, designed to discriminate between healthy and diseased tissue.
The raw sequencing data is then processed through bioinformatics (e.g., the GemCode analysis software developed by 10x Genomics) to remove low-quality reads and to assign reads to their respective barcodes. Reads can be aligned to a reference genome or assembled de novo to generate long-range contigs. The read alignment step is important for determining the order and orientation of the long DNA fragments, and for identifying genomic variations, such as insertions or deletions.
Moreover, 239Pu and 240Pu cannot be chemically distinguished, so expensive and difficult isotope separation would be necessary to separate them. Weapons-grade plutonium is defined as containing no more than 7% 240Pu; this is achieved by only exposing 238U to neutron sources for short periods of time to minimize the 240Pu produced (this also importantly reduces the short-lived isotopes 238Pu and 241Pu, and the 241Am from decay of the latter). Plutonium is classified according to the percentage of the contaminant plutonium-240 that it contains:
16 October An overview of detecting life on Earth from distant star-based systems is published. Scientists propose a new law of evolution, extending the established Darwinian ones, and described as the "law of increasing functional information". 21 species in the United States are declared extinct by the US Fish and Wildlife Service. These are one mammal, ten birds, two fish, and eight mussels. Scientists report the facial reconstruction of Pierolapithecus catalaunicus, a 12 million years old great ape. 19 October Astronomers report that FRB 20220610A, a Fast Radio Burst, took 8 billion years to reach Earth. Astronomers report the finding, for the first time, of Ultra-Fast Radio Bursts lasting millionths of a second. A new edge-based computer processor called NorthPole is developed by IBM Research, able to run AI-based image recognition apps 22 times faster than chips currently on the market. A study links a large marine macrofauna population collapse mortality event, the death of ~10 billion snow crabs around 2018, to marine heatwaves that caused mass starvation. 20 October – A study reports evidence of recent plant adaptive evolution, involving a leaf color change from green to red of a woodsorrel, due to urban heat islands. It provides information regarding evolutionary dynamics of climate change and human adaptation. 23 October – A significant breakthrough in treating cervical cancer is reported, with participants in a Phase III trial seeing a 35% reduction in the risk of both mortality or the disease returning.
Sources: en.wikipedia.org
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.
No. Cardarine is not a steroid hormone; it targets the nuclear receptor PPARδ. Its classification in anti-doping rules differs from anabolic steroids, though it remains prohibited in sport.
Early rodent studies reported tumor formation at multiple sites, which raised safety concerns. Sponsors stopped clinical development, and no approved human product exists.
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.